On the role of topical glucocorticosteroids in treatment of atopic dermatitis inchildren

Cite item


The article discusses the role of topical glucocorticosteroids in treatment of children suffering from atopic dermatitis as well as
problems of clinical efficacy and safety of application of mometasone furoate (Elocom®) for this dermatosis during the period of

About the authors

A L Bakulev

Email: al_ba05@mail.ru

N N Murashkin


  1. Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years . Clinical guideline 57. London 2007: 1-37.
  2. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006: 61: 969-987.
  3. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis . JEADV 2009.
  4. Grimalt R, Mengeaud V, Cambazard F, Study Investigators' Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214: 61-67
  5. Boussault P, Le´aute´-Labre`ze C, Saubusse E et al. Oat sensitization in children with atopic dermatitis: prevalence, risks and associated factors. Allergy 2007; 62: 1251-1256.
  6. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1-191.
  7. Van der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, CoenraadsPJ. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol 1999; 140: 1114-1121.
  8. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients . Br J Dermatol 2002; 147: 528-537.
  9. Berth-Jones J, Damstra RJ, Golsch S et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326: 1367.

Copyright (c) 2010 Bakulev A.L., Murashkin N.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies